Yes! When beginning the development of a disease-specific OSVP model, IVI recruits a Clinical Scientific Advisor with relevant expertise to join the modeling team. Dr. Jeff Curtis, a rheumatologist and professor at the University of Alabama Birmingham, serves in this capacity on the IVI-RA decision model. For the IVI-NSCLC decision model, this clinical expertise is provided by Dr. Karen Reckamp co-director of the Lung Cancer and Thoracic Oncology Program at City of Hope.
In addition, other providers and provider groups are consulted during initial model development, and providers are strongly encouraged to provide feedback during public comment periods. Clinicians also serve on each model’s Technical Expert Panel, an objective group of subject-matter experts that reviews public comments and develops recommendations for improvement of IVI’s models.